Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.

Xu-Monette, Zijun Y; Li, Ling; Byrd, John C; Jabbar, Kausar J; Manyam, Ganiraju C; Maria de Winde, Charlotte; van den Brand, Michiel; Tzankov, Alexandar; Visco, Carlo; Wang, Jing; Dybkaer, Karen; Chiu, April; Orazi, Attilio; Zu, Youli; Bhagat, Govind; Richards, Kristy L; Hsi, Eric D; Choi, William W L; Huh, Jooryung; Ponzoni, Maurilio; Ferreri, Andrés J M; Møller, Michael B; Parsons, Ben M; Winter, Jane N; Wang, Michael; Hagemeister, Frederick B; Piris, Miguel A; Han van Krieken, J; Medeiros, L Jeffrey; Li, Yong; van Spriel, Annemiek B; Young, Ken H

Xu-Monette, Zijun Y; Li, Ling; Byrd, John C; Jabbar, Kausar J; Manyam, Ganiraju C; Maria de Winde, Charlotte; van den Brand, Michiel; Tzankov, Alexandar; Visco, Carlo; Wang, Jing; Dybkaer, Karen; Chiu, April; Orazi, Attilio; Zu, Youli; Bhagat, Govind; Richards, Kristy L; Hsi, Eric D; Choi, William W L; Huh, Jooryung; Ponzoni, Maurilio; Ferreri, Andrés J M; Møller, Michael B; Parsons, Ben M; Winter, Jane N; Wang, Michael; Hagemeister, Frederick B; Piris, Miguel A; Han van Krieken, J; Medeiros, L Jeffrey; Li, Yong; van Spriel, Annemiek B; Young, Ken H.

Afiliação

Xu-Monette ZY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Li L; Department of Oncology, The First Affiliated Hospital Zhengzhou University, Zhengzhou, China.
Byrd JC; Department of Hematology and Oncology, The Ohio State University, Columbus, OH.
Jabbar KJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Manyam GC; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Maria de Winde C; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
van den Brand M; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Tzankov A; University Hospital, Basel, Switzerland.
Visco C; San Bortolo Hospital, Vicenza, Italy.
Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Dybkaer K; Aalborg University Hospital, Aalborg, Denmark.
Chiu A; Memorial Sloan Kettering Cancer Center, New York, NY.
Orazi A; Department of Pathology, Weill Medical College of Cornell University, New York, NY.
Zu Y; Department of Pathology, The Methodist Hospital, Houston, TX.
Bhagat G; Department of Pathology, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY.
Richards KL; Department of Hematology and Oncology, University of North Carolina School of Medicine, Chapel Hill, NC.
Hsi ED; Cleveland Clinic, Cleveland, OH.
Choi WW; Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Huh J; Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea.
Ponzoni M; San Raffaele H. Scientific Institute, Milan, Italy.
Ferreri AJ; San Raffaele H. Scientific Institute, Milan, Italy.
Møller MB; Odense University Hospital, Odense, Denmark.
Parsons BM; Gundersen Lutheran Health System, La Crosse, WI.
Winter JN; Feinberg School of Medicine, Northwestern University, Chicago, IL.
Wang M; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Hagemeister FB; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Piris MA; Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Han van Krieken J; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Li Y; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH; and.
van Spriel AB; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Young KH; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Blood ; 128(26): 3083-3100, 2016 12 29.

Article em En | MEDLINE | ID: mdl-27760757

Assuntos

Linfócitos B/metabolismo; Linfoma Difuso de Grandes Células B/metabolismo; Linfoma Difuso de Grandes Células B/patologia; Antígenos CD20/genética; Antígenos CD20/metabolismo; Antígenos de Neoplasias/genética; Antígenos de Neoplasias/metabolismo; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Feminino; Perfilação da Expressão Gênica; Regulação Neoplásica da Expressão Gênica; Centro Germinativo/patologia; Humanos; Linfoma Difuso de Grandes Células B/tratamento farmacológico; Linfoma Difuso de Grandes Células B/genética; Masculino; Pessoa de Meia-Idade; Modelos Biológicos; Análise Multivariada; Mutação/genética; NF-kappa B/metabolismo; Prognóstico; Receptor de Morte Celular Programada 1/metabolismo; Transporte Proteico; Proteínas Proto-Oncogênicas c-myc/metabolismo; RNA Mensageiro/genética; RNA Mensageiro/metabolismo; Fatores de Risco; Análise de Sobrevida; Tetraspaninas/genética; Tetraspaninas/metabolismo; Resultado do Tratamento; Proteína Supressora de Tumor p53/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Linfoma Difuso de Grandes Células B Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google